Frontiers in Immunology (Aug 2017)

Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans

  • Wivine Burny,
  • Andrea Callegaro,
  • Viviane Bechtold,
  • Frédéric Clement,
  • Sophie Delhaye,
  • Laurence Fissette,
  • Michel Janssens,
  • Geert Leroux-Roels,
  • Arnaud Marchant,
  • Robert A. van den Berg,
  • Nathalie Garçon,
  • Robbert van der Most,
  • Arnaud M. Didierlaurent,
  • On Behalf of the ECR-002 Study Group,
  • Viviane Bechtold,
  • Wivine Burny,
  • Andrea Callegaro,
  • Isabelle Carletti,
  • Frédéric Clement,
  • Sophie Delhaye,
  • Arnaud Didierlaurent,
  • Meral Esen,
  • Laurence Fissette,
  • Julian Gabor,
  • Nathalie Garçon,
  • Edwige Haelterman,
  • Caroline Hervé,
  • Yves Horsmans,
  • Michel Janssens,
  • Peter Kremsner,
  • Geert Leroux-Roels,
  • Arnaud Marchant,
  • Philippe Moris,
  • Tino F Schwarz,
  • Fernanda Tavares da Silva,
  • Pascale Van Belle,
  • Pierre Van Damme,
  • Robert A. van den Berg,
  • Robbert van der Most,
  • Dirk Zuchner

DOI
https://doi.org/10.3389/fimmu.2017.00943
Journal volume & issue
Vol. 8

Abstract

Read online

To elucidate the role of innate responses in vaccine immunogenicity, we compared early responses to hepatitis B virus (HBV) surface antigen (HBsAg) combined with different Adjuvant Systems (AS) in healthy HBV-naïve adults, and included these parameters in multi-parametric models of adaptive responses. A total of 291 participants aged 18–45 years were randomized 1:1:1:1:1 to receive HBsAg with AS01B, AS01E, AS03, AS04, or Alum/Al(OH)3 at days 0 and 30 (ClinicalTrials.gov: NCT00805389). Blood protein, cellular, and mRNA innate responses were assessed at early time-points and up to 7 days after vaccination, and used with reactogenicity symptoms in linear regression analyses evaluating their correlation with HBs-specific CD4+ T-cell and antibody responses at day 44. All AS induced transient innate responses, including interleukin (IL)-6 and C-reactive protein (CRP), mostly peaking at 24 h post-vaccination and subsiding to baseline within 1–3 days. After the second but not the first injection, median interferon (IFN)-γ levels were increased in the AS01B group, and IFN-γ-inducible protein-10 levels and IFN-inducible genes upregulated in the AS01 and AS03 groups. No distinct marker or signature was specific to one particular AS. Innate profiles were comparable between AS01B, AS01E, and AS03 groups, and between AS04 and Alum groups. AS group rankings within adaptive and innate response levels and reactogenicity prevalence were similar (AS01B ≥ AS01E > AS03 > AS04 > Alum), suggesting an association between magnitudes of inflammatory and vaccine responses. Modeling revealed associations between adaptive responses and specific traits of the innate response post-dose 2 (activation of the IFN-signaling pathway, CRP and IL-6 responses). In conclusion, the ability of AS01 and AS03 to enhance adaptive responses to co-administered HBsAg is likely linked to their capacity to activate innate immunity, particularly the IFN-signaling pathway.

Keywords